ARCHIVES

FDA Rile Changes Reporting Requirements for Adverse Events

This article is from The Cancer Letter archive.

Vol. 20 No. 44 | November 18, 1994

Download PDF Visit The Full Archive

Related Articles

In Brief: ONS, ASCO AACR Meetings Open In St. Louis Next Week; Bristol-Myers Adds Farber, McArdle Grants

April 16, 1982

ASCO Guidelines On CSFs Call For Use In Fewer Patients

December 2, 1994

NIEHS Awards $5M Grant for New Health Sciences Center to Robert Wood Johnson Medical School

January 20, 1989

In Brief: What’s In A Name? DRCCA Doesn’t Do It; O’Conor Says ICRDB Program Should Consider New Challenges

October 3, 1980

Longer Infusion More Effective For Pancreatic Cancer

September 26, 2003

National Action Plan Issues RFA For Grant Supplements

April 21, 1995